Hepatocellular carcinoma (HCC), the most common primary malignancy of the liver, represents
1 of the leading causes of cancer deaths in the world with an estimated 21,670 deaths in …

Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the second leading
cause of cancer-related mortality worldwide. In this review, we made a review on current …

… exists, the Barcelona Clinic Liver Cancer (BCLC) staging system has emerged as the standard
classification to assist clinical management decisions and for clinical trial entry of patients …

… The imaging features of the mass are consistent with hepatocellular carcinoma. … EASL
Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.  …

Purpose Hepatocellular carcinoma (HCC), a common cause for cancer-related death, is
increasing worldwide. Over the past decade, survival and quality of life of HCC patients have …

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy. Despite
efforts for prevention and screening as well as development of new technologies for diagnosis …

… tip: Hepatocellular carcinoma is an increasing health problem, representing the second
cause of cancer-related mortality worldwide. The major risk factor for hepatocellular carcinoma (…

Hepatocellular carcinoma (HCC) is one of the most common tumors globally, with varying
prevalence based on endemic risk factors. In high-risk populations, including those with …

These recommendations provide a data-supported approach to the diagnosis, staging and
treatment of patients diagnosed with hepatocellular carcinoma (HCC). They are based on the …

Hepatocellular carcinoma (HCC) generally develops as a consequence of underlying liver
disease, most commonly viral hepatitis. The development of HCC follows an orderly …